The value of fludarabine in addition to Ara-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML

GJ Ossenkoppele, WJ Graveland, Pieter Sonneveld, SMGJ Daenen, DH Biesma, LF Verdonck, MR Schaafsma, PHM Westveer, GJ Peters, P Noordhuis, P Muus, Ronnie van der Holt, M Delforge, Bob Löwenberg, GEG Verhoef

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1-1
Number of pages1
Publication statusPublished - 2003

Cite this